William Grossman

Insider Reports History

Location
Houston, TX
Signature
/s/ Charles N. York II, as Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by William Grossman:

Company Role Class Num Shares Value Price $ Report Date Ownership
Arcus Biosciences, Inc. Chief Medical Officer Common Stock 20,723 $414,460 $20.00 17 Jun 2021 Direct
enGene Holdings Inc. Director Stock Option (Right to Buy) 45,000 08 Jul 2025 Direct
Day One Biopharmaceuticals, Inc. Director Stock Option (right to buy Common Stock) 32,335 06 Nov 2025 Direct
Day One Biopharmaceuticals, Inc. Director Restricted Stock Unit (RSU) 15,000 02 Jun 2025 Direct

Insider Reports Filed by William Grossman

Symbol Company Period Transactions Value $ Form Type Role Filing Time
DAWN Day One Biopharmaceuticals, Inc. 06 Nov 2025 4 $0 4 Director 07 Nov 2025, 17:59
ENGN enGene Holdings Inc. 08 Jul 2025 1 $0 4 Director 10 Jul 2025, 16:06
ENGN enGene Holdings Inc. 08 Jul 2025 0 $0 3 Director 08 Jul 2025, 16:10
DAWN Day One Biopharmaceuticals, Inc. 02 Jun 2025 2 $0 4 Director 04 Jun 2025, 17:54
DAWN Day One Biopharmaceuticals, Inc. 23 May 2024 1 $0 4 Director 28 May 2024, 18:44
DAWN Day One Biopharmaceuticals, Inc. 17 Jan 2024 1 $0 4 Director 19 Jan 2024, 17:22
DAWN Day One Biopharmaceuticals, Inc. 17 Jan 2024 0 $0 3 Director 19 Jan 2024, 17:09
RCUS Arcus Biosciences, Inc. 16 Jun 2021 3 -$168,809 4 Chief Medical Officer 21 Jun 2021, 16:48